If Barrett’s esophagus becomes cancerous and becomes adenocarcinoma of the esophagus, the five-year survival rate varies depending on how early or late the lesion itself is staged. If it turns into esophageal adenocarcinoma, the five-year survival rate is more than 95% in the early stage, 20-30% in the middle stage, and 0 in the late stage.
Short-segment Barrett’s esophagus. This type of Barrett’s esophagus is generally considered to be a benign disease, and if the patient goes to the hospital in time and is treated by a professional doctor, it usually does not affect the life expectancy.
Long Barrett’s esophagus. This type of Barrett’s esophagus has the possibility of malignant changes. If Barrett’s esophagus undergoes endoscopic examination and treatment in a regular hospital, and if Barrett’s esophagus becomes cancerous and becomes esophageal adenocarcinoma, the five-year survival rate varies according to the early or late staging of the lesion itself.
When Barrett’s esophagus is not detected in time, and when it is accompanied by heterogeneous hyperplasia, there is a possibility that Barrett’s esophagus may turn into esophageal adenocarcinoma, a type of esophageal cancer, with the passage of time. The patient’s survival will decrease. The five-year survival rate for early stage esophageal adenocarcinoma is more than 95%, for intermediate stage 20 to 30%, and for advanced stage 0.
Symptoms of early esophageal adenocarcinoma are mostly atypical, and most of them manifest as discomfort, burning sensation or pinprick pain behind the sternum. Gastroscopy suggests that cancer cells only exist in the mucosal layer or submucosal layer, without invading into the muscle layer, without lymph node and distant organ metastasis.
Middle and advanced esophageal adenocarcinoma most typically presents with progressive dysphagia, which may also be accompanied by other symptoms such as food reflux and pain in swallowing, etc. Patients with advanced stage may be malignant or accompanied by metastasis to lymph nodes and distant organs such as liver and lungs.